Pre-operative hypoalbuminemia is associated with increased mortality in patients undergoing surgery for gynecologic malignancy - A retrospective cohort study.

[1]  D. McMillan,et al.  Hypoalbuminemia Reflects Nutritional Risk, Body Composition and Systemic Inflammation and Is Independently Associated with Survival in Patients with Colorectal Cancer , 2020, Cancers.

[2]  A. Miners,et al.  The clinical and cost-effectiveness of supplemental parenteral nutrition in oncology , 2020, ESMO Open.

[3]  Q. Kan,et al.  Low preoperative serum ALB level is independently associated with poor overall survival in endometrial cancer patients. , 2020, Future oncology.

[4]  E. Miralpeix,et al.  Role and impact of multimodal prehabilitation for gynecologic oncology patients in an Enhanced Recovery After Surgery (ERAS) program , 2019, International Journal of Gynecological Cancer.

[5]  T. Bartl,et al.  Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery , 2019, Archives of Gynecology and Obstetrics.

[6]  Jiwei Huang,et al.  Association of post-treatment hypoalbuminemia and survival in Chinese patients with metastatic renal cell carcinoma , 2017, Chinese journal of cancer.

[7]  Hua-min Zheng,et al.  A novel prognostic inflammation score predicts outcomes in patients with ovarian cancer. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[8]  A. Weaver,et al.  Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer. , 2016, Gynecologic oncology.

[9]  P. D. L. David L. Morris MD,et al.  Impacts of Preoperative Serum Albumin Level on Outcomes of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy , 2016, Annals of Surgical Oncology.

[10]  W. Miller,et al.  A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery. , 2015, Gynecologic oncology.

[11]  B. Ataseven,et al.  Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. , 2015, Gynecologic oncology.

[12]  Jason D. Wright,et al.  Risk stratification and outcomes of women undergoing surgery for ovarian cancer. , 2015, Gynecologic oncology.

[13]  J. Smolle,et al.  The influence of elevated levels of C‐reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment , 2014, Journal of surgical oncology.

[14]  D. Kushner,et al.  Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies. , 2013, Gynecologic oncology.

[15]  W. Hofmann,et al.  Characteristics, Treatment and Prognostic Factors of Patients with Gynaecological Malignancies Treated in a Palliative Care Unit at a University Hospital , 2013, Oncology Research and Treatment.

[16]  M. Einstein,et al.  Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010. , 2013, Gynecologic oncology.

[17]  M. Kattan,et al.  Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. , 2012, Gynecologic oncology.

[18]  J. Lee,et al.  Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer , 2012, Medical Oncology.

[19]  W. Cliby,et al.  Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization. , 2011, Gynecologic oncology.

[20]  M. Spillman,et al.  Surgical Risk Score Predicts Suboptimal Debulking or a Major Perioperative Complication in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer , 2011, International Journal of Gynecologic Cancer.

[21]  J. Lucci,et al.  Malnutrition as a predictor of poor postoperative outcomes in gynecologic cancer patients , 2011, Archives of Gynecology and Obstetrics.

[22]  D. Chi,et al.  A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model. , 2007, Gynecologic oncology.

[23]  N. Soni,et al.  Serum albumin: touchstone or totem? , 1998, Anaesthesia.

[24]  B. Naylor,et al.  Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer , 1994, British journal of obstetrics and gynaecology.